Transforming Oral Disease and Wound Treatment
Emanate is improving outcomes with
Precision Oral Diffusion Systems (PODS™)
UNMET NEED
The mouth is the mirror of health and disease in the body.
However, the treatment and management of oral diseases and wounds has not changed in decades. Dental healthcare professionals continue to primarily rely on painful, in-office interventions. Given the prevalence of oral diseases, aging populations and increased knowledge of the oral-systemic health connection, there is a pressing need for new clinically effective oral health treatment modalities.
About
A category-defining platform to address the most important unmet clinical needs in oral health.
Founded by a practicing dentist and a medtech entrepreneur, Emanate’s patented technology—personalized single-use preloaded hydrogel-infused dental trays—will transform the standard of care for oral diseases and wounds.
Emanate is headquartered in New York with a dedicated R&D center in the San Francisco Bay Area and backed by leading healthcare technology investors.
Team
Emanate built a team of proven medical device and oral health executives.
Jarret Fass
Founder and CEO
Dr. Peter Zegarelli
Co-Founder and
Chief Clinical Officer
Dr. Jacques Seguin
Chairman
Dorna Hakimi, PhD
Chief Technology Officer
Kenneth Gomez
Director of
Analytical Chemistry
Tom Huljev
Senior Consulting
Engineer,
LamaMed
Dr. Jan Lessem
Chief Medical Officer
Jill Bossi
Director of
Clinical Operations
Mary Hirtle
Director of Finance
John Brouder
Industry Advisor
Dr. Dana Graves
Clinical Advisor
Rich Hirschland
Industry Advisor
David Leeson
Manufacturing Advisor
Dr. Ben Miraglia
Clinical Advisor
Eric Nodiff
Industry Advisor
Russ Secter
Industry Advisor
Dr. Lou Shuman
Industry Advisor
David Thrower
Industry Advisor
Amir Abolfathi
Industry Advisor
Dr. Steve Sonis
Clinical Advisor
Dr. Panos Papapanou
Clinical Advisor